Update on venous thromboembolism: risk factors, mechanisms, and treatments.

Articles in this series • Machlus KR, Aleman MM, Wolberg AS. Update on venous thromboembolism: risk factors, mechanisms, and treatments. Arterioscler Thromb Vasc Biol. 2011;31:476–478. • Popuri RK, Vedantham S. The role of thombolysis in the clinical management of deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2011;31:479–484. • Smalberg JH, Kruip MJHA, Janssen HLA, Rijken DC, Leebeek FWG, de Maat MPM. Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences. Arterioscler Thromb Vasc Biol. 2011;31:485–493. • Lord ST. Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol. 2011;31:494–499. • Xu Z, Kamocka M, Alber M, Rosen ED. Computational approaches to studying thrombus development. Arterioscler Thromb Vasc Biol. 2011;31:500–505. • Saha P, Humphries J, Modarai B, Mattock K, Waltham M, Evans CE, Ahmad A, Patel AS, Premaratne S, Lyons OTA, Smith A. Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Arterioscler Thromb Vasc Biol. 2011;31:506–512.